IBoron

-Delile

• Cishe iyasebenza ...
• Kungenzeka kusebenze ...
• Kungenzeka kungasebenzi ku ...
• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

IBoron yiminerali etholakala ekudleni okufana namantongomane nemvelo. Abantu bathatha izithasiselo ze-boron njengomuthi.

IBoron isetshenziselwa ukushoda kwe-boron, amajaqamba okuya esikhathini, kanye nokutheleleka ngemvubelo esithweni sangasese sowesifazane. Kwesinye isikhathi kusetshenziselwa ukusebenza kwezemidlalo, i-osteoarthritis, amathambo abuthakathaka noma aqhekekile (i-osteoporosis), nezinye izimo, kepha alukho ucwaningo lwesayensi oluhle lokuxhasa lokhu okunye ukusetshenziswa.

IBoron yasetshenziswa njengendawo yokulondoloza ukudla phakathi kuka-1870 no-1920, nangesikhathi seMpi Yezwe I no-II.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze UBORON zimi kanje:

Cishe iyasebenza ...

• Ukushoda kweBoron. Ukuthatha i-boron ngomlomo kuvimbela ukushoda kwe-boron.

Kungenzeka kusebenze ...

• Izikhukhula zokuya esikhathini (i-dysmenorrhea). Olunye ucwaningo lukhombisa ukuthi ukuthatha i-boron 10 mg ngomlomo nsuku zonke ngesikhathi sokuphuma kokuya esikhathini kunciphisa ubuhlungu kwabesifazane abasebasha abanezikhathi ezibuhlungu.
• Ukutheleleka kwemvubelo yesitho sangasese sowesifazane. Olunye ucwaningo lukhombisa ukuthi i-boric acid, esetshenziswe ngaphakathi esithweni sangasese, ingaphatha ngempumelelo imvubelo yezifo (i-candidiasis), kufaka phakathi izifo ezingabonakali zingcono ngeminye imithi nokwelashwa. Kodwa-ke, ikhwalithi yalolu cwaningo iyabuzwa.

Kungenzeka kungasebenzi ku ...

• Ukusebenza kwezemidlalo. Ukuthatha i-boron ngomlomo akubonakali kuthuthukisa isisindo somzimba, imisipha, noma amazinga e-testosterone kuma-bodybuilders wesilisa.

Ubufakazi obanele bokukala ukusebenza kwe ...

• Nciphisa amakhono wokukhumbula nokucabanga okwenzeka ngokujwayelekile ngobudala. Ucwaningo lokuqala lukhombisa ukuthi ukuthatha i-boron ngomlomo kungathuthukisa ukufunda, inkumbulo, kanye namakhono amahle emoto kubantu asebekhulile.
• I-osteoarthritis. Ucwaningo lokuqala lubonisa ukuthi i-boron ingaba wusizo ekunciphiseni ubuhlungu obuhlobene nesifo samathambo.
• Amathambo abuthakathaka futhi anamandla (i-osteoporosis). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-boron ngomlomo nsuku zonke akuthuthukisi ithambo kwabesifazane be-postmenopausal.
• Ukulimala kwesikhumba okubangelwa ukwelashwa ngemisebe (i-radiation dermatitis). Ucwaningo lwakuqala lukhombisa ukuthi ukusebenzisa i-boron-based gel amahlandla ama-4 ngosuku endaweni yesikhumba elashwa ngemisebe yomdlavuza webele kungavimbela ukuqubuka kwesikhumba okuhlobene nemisebe.
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala ukusebenza kwe-boron kulokhu kusetshenziswa.

IBoron ibukeka iyithinta indlela umzimba ophatha ngayo amanye amaminerali afana ne-calcium, i-magnesium ne-phosphorus. Kubukeka sengathi kukhuphula amazinga e-estrogen kwabesifazane asebekhulile (abangemuva kokuya esikhathini) nabesilisa abaphilile. I-Estrogen kucatshangwa ukuthi iyasiza ekugcineni amathambo aphilile nokusebenza kwengqondo. I-Boric acid, uhlobo olujwayelekile lwe-boron, ingabulala imvubelo ebanga ukutheleleka kwesitho sangasese sowesifazane. I-Boron ingaba nemiphumela yokulwa ne-antioxidant.

Lapho ithathwa ngomlomo: IBoron inguye CISHE UVIKILE lapho ithathwa ngomlomo ngemithamo engadluli kuma-20 mg ngosuku. UBoron unjalo MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngomlomo ngemithamo ephakeme. Kukhona okunye ukukhathazeka ukuthi imithamo engaphezu kuka-20 mg ngosuku ingalimaza ikhono lowesilisa lokuzala ingane. Inani elikhulu le-boron nalo lingadala ubuthi. Izimpawu zobuthi zifaka ukuvuvukala kwesikhumba nokuxebuka, ukucasuka, ukuthuthumela, ukudlikizela, ubuthakathaka, ikhanda elibuhlungu, ukudangala, uhudo, ukuhlanza nezinye izimpawu.

Lapho isetshenziswa esithweni sangasese: I-Boric acid, uhlobo oluvamile lwe-boron, yi CISHE UVIKILE uma isetshenziswa esithweni sangasese kuze kube izinyanga eziyisithupha. Kungadala umuzwa wokusha kwesitho sangasese sowesifazane.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: IBoron inguye CISHE UVIKILE kwabesifazane abakhulelwe nabancelisayo abaneminyaka yobudala eyi-19-50 lapho besetshenziswa ngemithamo engaphansi kuka-20 mg ngosuku. Abesifazane abakhulelwe nabancelisayo abaneminyaka engu-14 kuya kwengu-18 akufanele bathathe ngaphezu kuka-17 mg ngosuku. Ukuthatha i-boron ngomlomo ngemithamo ephezulu MHLAWUMBI ANGIPHEPHILE ngenkathi ukhulelwe futhi uncelisa ibele. Amanani aphezulu angaba yingozi futhi akufanele asetshenziswe ngabesifazane abakhulelwe ngoba kuxhunyaniswe nezisindo zokuzalwa eziphansi kanye nezinkinga zokuzalwa. I-intravaginal boric acid ihlotshaniswe nengcuphe eyengeziwe engu-2.7 kuya ku-2.8 ephindwe kabili yokukhubazeka kokuzalwa lapho isetshenziswa ezinyangeni ezine zokuqala zokukhulelwa.

Izingane: IBoron inguye CISHE UVIKILE lapho isetshenziswa ngemithamo engaphansi kwe-Upper Tolerable Limit (UL) (bheka isigaba somthamo ngezansi). UBoron unjalo MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngomlomo ngemithamo ephakeme. Ubuningi be-boron bungadala ubuthi. I-Boric acid powder, uhlobo oluvamile lwe-boron, yi MHLAWUMBI ANGIPHEPHILE lapho isetshenziswa ngamanani amakhulu ukuvimbela ukuqubuka kwe-diaper.

Isimo esizwela i-Hormone njengomdlavuza webele, umdlavuza wesibeletho, umdlavuza we-ovari, i-endometriosis, noma i-uterine fibroids: I-Boron ingahle isebenze njenge-estrogen. Uma unanoma isiphi isimo esingahle senziwe sibi ngokuvezwa yi-estrogen, gwema i-boron eyengeziwe noma inani eliphakeme le-boron ekudleni.

Isifo sezinso noma izinkinga zokusebenza kwezinso: Ungathathi izithasiselo ze-boron uma unezinkinga zezinso. Izinso kufanele zisebenze kanzima ukukhipha i-boron.

Maphakathi

Qaphela ngale nhlanganisela.

Ama-Estrogens

IBoron ingakhuphula amazinga e-estrogen emzimbeni. Ukuthatha i-boron kanye ne-estrogens kungadala i-estrogen eningi emzimbeni.

Amanye ama-estrogen aqukethe imishanguzo yi-estradiol (i-Estrace, i-Vivelle), i-conjugated estrogens (i-Premarin), imishanguzo yomlomo yokuvimbela inzalo (i-Ortho Tri-Cyclen, iSprintec, i-Aviane) neminye eminingi.

Magnesium

Izithako zeBoron zinganciphisa inani le-magnesium elikhishwe emchameni. Lokhu kungaholela emazingeni egazi we-magnesium aphakeme kunokujwayelekile. Phakathi kwabesifazane asebekhulile, lokhu kubonakala kwenzeka kaningi kwabesifazane abangatholi i-magnesium eningi ekudleni kwabo. Phakathi kwabesifazane abasebasha, umphumela ubonakala mkhulu kwabesifazane abazivocavoca kancane. Akekho owaziyo ukuthi lokhu kutholakala kubaluleke kangakanani empilweni, noma ngabe kwenzeka emadodeni.

I-Phosphorus

I-boron eyengeziwe inganciphisa amazinga e-phosphorus egazi kwabanye abantu.

Akukho ukuxhumana okwaziwayo nokudla.

Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

ABADALA

NGOMLOMO:

• Ngezikhathi ezibuhlungu: IBoron 10 mg nsuku zonke kusuka ezinsukwini ezimbili ngaphambi kwezinsuku ezintathu ngemuva kokuqala kokuya esikhathini.

• Akunasincomo se-Daily Allowance (RDA) esinconyelwe i-boron ngoba indima ebalulekile yebhayoloji yayo ayikabonwa. Abantu badla amanani ahlukahlukene we-boron ngokuya ngokudla kwabo. Ukudla okubhekwa njengokuphezulu ku-boron kunikela cishe ngo-3.25 mg we-boron ngo-2000 kcal ngosuku. Ukudla okubhekwa njengokuncane ku-boron kunikela ngo-0.25 mg we-boron ngo-2000 kcal ngosuku.
  
  I-Tolerable Upper Intake Level (UL), isilinganiso esiphezulu lapho kungalindelekile imiphumela emibi, ingama-20 mg ngosuku kubantu abadala nabesifazane abakhulelwe noma abancelisa izingane abaneminyaka engaphezu kwengu-19 ubudala.

NGESIVULEKILE:

• Ngokutheleleka esithweni sangasese: 600 mg we-boric acid powder kanye noma kabili ngosuku.

IZINGANE

NGOMLOMO:

• Jikelele: Akukho okunconyelwe iDaily Allowance (RDA) ye-boron ngoba indima ebalulekile kuyo ayikaziwa. Izinga Lokungenisa Elingenakubekezeleleka (i-UL), isilinganiso esiphezulu lapho kungalindelekile ukuthi kube nemiphumela emibi, singu-17 mg ngosuku kubantu abasha abaneminyaka engu-14 kuya kwengu-18 ubudala nabesifazane abakhulelwe noma abancelisa abaneminyaka engu-14 kuya kwengu-18 ubudala. Ezinganeni ezineminyaka engu-9 kuya kwengu-13 ubudala, i-UL ingu-11 mg ngosuku; izingane ezineminyaka engu-4 kuya kwengu-8 ubudala, 6 mg ngosuku; nezingane ezineminyaka engu-1 kuya kwengu-3 ubudala, 3 mg ngosuku. I-UL ayisungulwanga izingane.

I-Acide Borique, i-Anhydride Borique, inombolo ye-Atomic 5, B (uphawu lwamakhemikhali), B (symbole chimique), Borate, Borate de Sodium, Borates, Bore, Boric Acid, Boric Anhydride, Boric Tartrate, Boro, Numéro Atomique 5, Sodium Borate.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. UHjelm C, Harari F, Vahter M. Ukuchayeka kwe-boron kwezemvelo ngaphambi nangemva kokubeletha nokukhula kwezinsana: imiphumela evela eqenjini lomama nengane enyakatho ye-Argentina. I-Environ Res 2019; 171: 60-8. Buka okungaqondakali.
2. UKuru R, Yilmaz S, Balan G, et al. Ukudla okunothe ngeBoron kungalawula iphrofayili ye-lipid yegazi futhi kuvimbele ukukhuluphala: isilingo somtholampilo esingewona umuthi nesizilawulayo. UJ Trace Elem Med Biol 2019; 54: 191-8. Buka okungaqondakali.
3. Aysan E, Idiz UO, Elmas L, Saglam EK, Akgun Z, Yucel SB. Imiphumela yejeli esuselwa ku-boron ku-dermatitis eyenziwe ngemisebe emdlavuzeni webele: isilingo esilawulwa kabili, esilawulwa yi-placebo. J Invest Surg 2017; 30: 187-192. i-doi: 10.1080 / 08941939.2016.1232449. Buka okungaqondakali.
4. UNikkhah S, uDolatian M, uNaghii MR, uZaeri F, uTaheri SM. Imiphumela ye-boron supplementation ebukhulwini nobude besikhathi sobuhlungu ku-dysmenorrhea eyinhloko. Qedela iTher Clin Pract 2015; 21: 79-83. Buka okungaqondakali.
5. INewnham RE. Indima ye-boron ekudleni komuntu. J Ukudla Okusetshenzisiwe 1994; 46: 81-85.
6. IGoldbloom RB kanye neGoldbloom A. Boron acid poisoning: umbiko wamacala amane nokubuyekezwa kwamacala ayi-109 avela ezincwadini zomhlaba. J Pediatrics 1953; 43: 631-643.
7. UValdes-Dapena MA no-Arey JB. Ubuthi be-Boric acid. UJ Pediatr 1962; 61: 531-546.
8. IBiquet I, uCollette J, uDauphin JF, no-et al. Ukuvimbela ukulahleka kwethambo kwe-postmenopausal ngokuphathwa kwe-boron. I-Osteoporos Int 1996; 6 Suppl 1: 249.
9. I-Travers RL noRennie GC. Isivivinyo somtholampilo: i-boron ne-arthritis. Imiphumela yesifundo somshayeli oyimpumputhe esiphindwe kabili. I-Townsend Lett Doctors 1990; 360-362.
10. Abahamba i-RL, uRennie GC, noNewnham RE. I-Boron ne-arthritis: imiphumela yocwaningo lokushayela okuyimpumputhe. J Ukudla okunomsoco Med 1990; 1: 127-132.
11. UNielsen FH noPenland JG. Ukwengezwa kweBoron kwabesifazane be-peri-menopausal kuthinta i-boron metabolism kanye nama-indices ahambisana ne-macromineral metabolism, isimo se-hormonal nokusebenza komzimba. J Trace Elements Yokuhlola Med 1999; 12: 251-261.
12. Prutting, S. M. noCerveny, J. D. Boric acid suppositories sangasese: ukubuyekeza okufushane. Ukutheleleka.Dis Obstet.Gynecol. 1998; 6: 191-194. Buka okungaqondakali.
13. I-Limaye, S. ne-Weightman, W. Umphumela wamafutha aqukethe i-boric acid, i-zinc oxide, isitashi ne-petrolatum ku-psoriasis. Ama-Australas. J Dermatol. 1997; 38: 185-186. Buka okungaqondakali.
14. UShinohara, Y. T. noTasker, S. A. Ukusetshenziswa ngempumelelo kwe-boric acid ukulawula i-azole-refractory Candida vaginitis kowesifazane one-AIDS. J Acquir.Imune.Defic.Syndr.Hum.Retrovirol. 11-1-1997; 16: 219-220. Buka okungaqondakali.
15. UHunt, C. D., Herbel, J. L., noNielsen, F. H. Izimpendulo zeMetabolic zabesifazane be-postmenopausal ukwengeza i-boron yokudla ne-aluminium ngesikhathi sokudla okujwayelekile futhi okuphansi kwe-magnesium: i-boron, i-calcium, ne-magnesium ukumunca nokugcinwa kanye nokugxila kwamaminerali egazi. NginguJ J Clin Nutr 1997; 65: 803-813. Buka okungaqondakali.
16. UMurray, F. J. Ukuhlolwa kwengozi yomuntu kwezempilo ye-boron (boric acid ne-borax) emanzini okuphuza. I-Toxicol Pharmacol. 1995; 22: 221-230. Buka okungaqondakali.
17. Ishii, Y., Fujizuka, N., Takahashi, T., Shimizu, K., Tuchida, A., Yano, S., Naruse, T., noChishiro, T. Icala elibulalayo lobuthi obunzima be-boric acid. UJ Toxicol Clin Toxicol 1993; 31: 345-352. Buka okungaqondakali.
18. UBeattie, uJ. H. no-Peace, uH. S. Ithonya lokudla okuphansi kwe-boron kanye ne-boron supplementation emathanjeni, emaminerali amakhulu nakwezocansi steroid metabolism kwabesifazane be-postmenopausal. UBr J Nutr 1993; 69: 871-884. Buka okungaqondakali.
19. UHunt, uC. D., uHerbel, uJ. J Bone Umvukuzi. 1994; 9: 171-182. Buka okungaqondakali.
20. UChapin, R. E. noKu, W. W. Ubuthi bokuzala be-boric acid. Isimo Sezempilo Sendawo. 1994; 102 Isengezo 7: 87-91. Buka okungaqondakali.
21. Woods, W. G. Isingeniso se-boron: umlando, imithombo, ukusetshenziswa, kanye namakhemikhali. Isimo Sezempilo. 1994; 102 Isengezo 7: 5-11. Buka okungaqondakali.
22. Hunt, C. D. Imiphumela yamakhemikhali yamanani we-physiologic we-boron yokudla kumamodeli wokudla kwezilwane. Isimo Sezempilo Sendawo. 1994; 102 Isengezo 7: 35-43. Buka okungaqondakali.
23. UVan Slyke, K. K., Michel, V. P., noRein, M. F. Ukwelashwa kwe-boric acid powder ye-vulvovaginal candidiasis. UJ Am Coll. I-Assoc Yezempilo 1981; 30: 107-109. Buka okungaqondakali.
24. Orley, J. Nystatin kuqhathaniswa ne-boric acid powder ku-candidiasis ye-vulvovaginal. NginguJ J Obstet. 12-15-1982; 144: 992-993. Buka okungaqondakali.
25. Lee, I. P., Sherins, R. J., noDixon, R. L. Ubufakazi bokungeniswa kwe-aplasia yegciwane kumagundane abesilisa ngokuchayeka kwemvelo ku-boron. I-Toxicol. Appl. Pharmacol 1978; 45: 577-590. Buka okungaqondakali.
26. UJansen, J. A., Andersen, J., noSchou, J. S. Boric acid umthamo owodwa we-pharmacokinetics ngemuva kokuphathwa ngemithambo kumuntu. I-Arch. Ubuthi. 1984; 55: 64-67. Buka okungaqondakali.
27. IGarabrant, D. H., Bernstein, L., Peters, J. M., noSmith, T. J. Ukuphefumula kanye nokucasulwa kwamehlo kusuka ku-boron oxide nakubhuqu lwe-boric acid. J Umsebenzi Med 1984; 26: 584-586. Buka okungaqondakali.
28. Linden, C.H, Hall, A. H., Kulig, K. W., noRumack, B. H. Ukungenisa okunamandla kwe-boric acid. UJ Toxicol Clin Toxicol 1986; 24: 269-279. Buka okungaqondakali.
29. I-Litovitz, T. L., Klein-Schwartz, W., Oderda, G. M., noSchmitz, B. F. Ukubonakaliswa kwemitholampilo yobuthi ochungechungeni lokufakwa okungu-784 boric acid. NginguJ Emerg. Phakathi kuka-1988; 6: 209-213. Buka okungaqondakali.
30. Benevolenskaia, LI, Toroptsova, NV, Nikitinskaia, OA, Sharapova, EP, Korotkova, TA, Rozhinskaia, LI, Marova, EI, Dzeranova, LK, Molitvoslovova, NN, Men'shikova, LV, Grudinina, OV, Lesniak, OM, I-Evstigneeva, i-LP, i-Smetnik, i-VP, i-Shestakova, i-IG, ne-Kuznetsov, i-SI [i-Vitrum osteomag ekuvikeleni i-osteoporosis kwabesifazane be-postmenopausal: imiphumela yesivivinyo sokuqhathanisa esivulekile esivamile]. I-Ter. 2004; 76: 88-93. Buka okungaqondakali.
31. URestuccio, A., Mortensen, M. E., noKelley, M. T. Ukungeniswa okubulalayo kwe-boric acid kumuntu omdala. NginguJ Emerg. I-Med 1992; 10: 545-547. Buka okungaqondakali.
32. UWallace, J. M., Hannon-Fletcher, M. P., Robson, P. J., Gilmore, W. S., Hubbard, S. A., no-Strain, J. J. Boron supplementation kanye ne-activated factor VII emadodeni aphilile. Eur.J Umsoco Wasemtholampilo. 2002; 56: 1102-1107. Buka okungaqondakali.
33. UFukuda, R., Hirode, M., Mori, I., Chatani, F., Morishima, H., noMayahara, H. Umsebenzi wokubambisana wokuhlola ubuthi ezithweni zokuzala zabesilisa ngezifundo eziphindwe kaningi zamagundane 24). Ubuthi obunobufakazi be-boric acid ngemuva kwezikhathi zokuphatha zamaviki ama-2- kanye nama-4. J Toxicol Sci 2000; 25 Inombolo Cha: 233-239. Buka okungaqondakali.
34. UHeindel JJ, Intengo ye-CJ, i-Field EA, et al. Ubuthi obuthuthukisayo be-boric acid kumagundane namagundane. IFundam Appl Toxicol 1992; 18: 266-77. Buka okungaqondakali.
35. Ama-Acs N, uBanhidy F, uPuho E, uCzeizel AE. Imiphumela ye-Teratogenic yokwelashwa kwe-vagic boric acid ngesikhathi sokukhulelwa. I-Int J Gynaecol Obstet 2006; 93: 55-6. Buka okungaqondakali.
36. UDi Renzo F, uCappelletti G, uBroccia ML, et al. I-Boric acid ivimbela i-embryonic histone deacetylases: indlela ephakanyisiwe yokuchaza i-boric acid ehlobene ne-teratogenicity. I-Appl Pharmacol 2007; 220: 178-85. Buka okungaqondakali.
37. UBleys J, Navas-Acien A, Guallar E. Serum selenium nesifo sikashukela kubantu abadala base-U.S. Ukunakekelwa yisifo sikashukela 2007; 30: 829-34. Buka okungaqondakali.
38. I-Sobel JD, Chaim W. Ukwelashwa kwe-Torulopsis glabrata vaginitis: ukubuyekeza okubuyiselwayo kokwelapha i-boric acid. I-Clin Infect Dis 1997; 24: 649-52. Buka okungaqondakali.
39. UMakela P, uLeaman D, uSobel JD. I-Vulvovaginal trichosporonosis. Igciwane le-Dis Obstet Gynecol 2003; 11: 131-3. Buka okungaqondakali.
40. Rein MF. Ukwelashwa kwamanje kwe-vulvovaginitis. Ubulili Transm Dis 1981; 8: 316-20. Buka okungaqondakali.
41. UJovanovic R, uCongema E, Nguyen HT. Ama-antifungal agents vs. i-boric acid yokwelapha i-mycotic vulvovaginitis engapheli. UJ Reprod Med 1991; 36: 593-7. Buka okungaqondakali.
42. I-Ringdahl EN. Ukwelashwa kwe-candidiasis evamile ye-vulvovaginal. NginguDokotela Wemindeni 2000; 61: 3306-12, 3317. Buka okungaqondakali.
43. UGuaschino S, uDe Seta F, uSartore A, et al. Ukusebenza kokwelashwa kwesondlo nge-topical boric acid uma kuqhathaniswa ne-itraconazole yomlomo ekwelapheni i-candidiasis evamile yensimbi. NginguJ J Obstet Gynecol 2001; 184: 598-602. Buka okungaqondakali.
44. USingh S, uSobel JD, uBhargava P, et al. I-Vaginitis ngenxa yeCandida krusei: isifo se-epidemiology, izici zomtholampilo, kanye nokwelashwa. I-Clin Infect Dis 2002; 35: 1066-70. Buka okungaqondakali.
45. UVan Kessel K, Assefi N, Marrazzo J, Eckert L. Imithi ejwayelekile ehambisanayo nezinye izindlela yokwelapha imvubelo ye-vaginitis kanye ne-bacterial vaginosis: ukubuyekeza okuhlelekile. I-Obstet Gynecol Surv 2003; 58: 351-8. Buka okungaqondakali.
46. Swate TE, Ukhula JC. Ukwelashwa kwe-Boric acid ye-vulvovaginal candidiasis. Isithiyo Gynecol 1974; 43: 893-5. Buka okungaqondakali.
47. USobel JD, Chaim W, Nagappan V, Leaman D. Ukwelashwa kwe-vaginitis okubangelwa yi-Candida glabrata: ukusetshenziswa kwe-topic boric acid ne-flucytosine. NginguJ J Obstet Gynecol 2003; 189: 1297-300. Buka okungaqondakali.
48. UVan Slyke KK, uMichel VP, uRein MF. Ukwelashwa kwe-candidiasis ye-vulvovaginal nge-boric acid powder. NginguJ J Obstet Gynecol 1981; 141: 145-8. Buka okungaqondakali.
49. Isi-Thai L, Hart LL. Ama-boric acid suppositories. U-Ann Pharmacother 1993; 27: 1355-7. Buka okungaqondakali.
50. IVolpe SL, Taper LJ, Meacham S. Ubudlelwano obuphakathi kwesimo se-boron ne-magnesium kanye nobuningi bamathambo kumuntu: ukubuyekeza. IMagnes Res 1993; 6: 291-6 .. Buka okungaqondakali.
51. UNielsen FH, uHunt CD, uMullen LM, uHunt JR. Imiphumela ye-boron yokudla kumaminerali, i-estrogen, ne-testosterone metabolism kwabesifazane be-postmenopausal. FASEB J 1987; 1: 394-7. Buka okungaqondakali.
52. UNielsen FH. Imiphumela ye-biochemical kanye ne-physiologic yokuncishwa kwe-boron ebantwini. I-Environ Health Perspect 1994; 102: 59-63 .. Buka okungaqondakali.
53. IBhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha. Ukufakwa Kwezikhombo Zezokudla ku-Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, neZinc. Washington, DC: National Academy Press, 2002. Itholakala ku: www.nap.edu/books/0309072794/html/.
54. UShils M, Olson A, Shike M. Ukondleka Kwamanje Ezempilo Nezifo. Umhlaka 8. IPhiladelphia, PA: Lea noF Febiger, 1994.
55. IGreen NR, uFerrando AA. I-Plasma boron kanye nemiphumela yokwengeza kwe-boron kwabesilisa. Isimo Sezempilo Sendawo 1994; 102: 73-7. Buka okungaqondakali.
56. IPenland JG. I-boron yokudla, ukusebenza kobuchopho, nokusebenza kwengqondo. Isimo Sezempilo Sendawo 1994; 102: 65-72. Buka okungaqondakali.
57. IMeacham SL, iTaper LJ, iVolpe SL. Imiphumela ye-boron supplementation kumathambo amaminerali kanye nokudla, igazi, ne-calcium yomchamo, i-phosphorus, i-magnesium ne-boron kubasubathi besifazane. I-Environ Health Perspect 1994; I-102 (iSuppl 7): 79-82. Buka okungaqondakali.
58. INewnham RE. Ukubaluleka kwe-boron ngamathambo namalunga aphilile. Umbono Wezempilo We-Environ 1994; 102: 83-5. Buka okungaqondakali.
59. IMeacham SL, iTaper LJ, iVolpe SL. Umphumela we-boron supplementation egazini naku-calcium yomchamo, i-magnesium, ne-phosphorus, kanye ne-uron boron kwabesifazane abagijimayo nabahlala phansi. Ngingu-J J Nutriti 1995; 61: 341-5. Buka okungaqondakali.
60. Usuda K, Kono K, Iguchi K, et al. Umthelela weHemodialysis ezingeni le-serum boron ezigulini ezine-hemodialysis yesikhathi eside. ISci Total Environ 1996; 191: 283-90. Buka okungaqondakali.
61. UNaghii MR, uSamman S. Umphumela we-boron supplementation ekukhishweni kwawo komchamo kanye nezici ezikhethiwe zobungozi benhliziyo ezifundweni zesilisa ezinempilo. I-Biol Trace Elem Res 1997; 56: 273-86. Buka okungaqondakali.
62. U-Ellenhorn MJ, et al. I-Ellenhorn's Medical Toxicology: Ukuxilongwa Nokulashwa Kobuthi Bomuntu. Okwesibili. IBaltimore, MD: Williams & Wilkins, 1997.

Kugcine ukubuyekezwa - 03/30/2020